By: Daniel R. Matlis, President
Improving Healthcare in the Outcome Economy
The Internet of Things (IoT) and the transition to the Outcome Economy were key themes at PTC’s LiveWorx16. The focus on IoT and Product Lifecycle Management (PLM) and the shift to outcome based models, sparked this analysis on the applicability of these trends in our “sick-care system.”
The traditional healthcare model could better be described as “sick-care.” Historically, healthcare has been episodic and reactive — primarily aimed at addressing a malady, illness or injury after it has already happened.
Here are a few examples:
This sick-care approach has it backwards, though. As the refrain goes, an ounce of prevention is worth a pound of cure. Furthermore, sick-care is expensive and unsustainable. But, can we apply the IoT, PLM, and outcome-based models to healthcare? Continue reading
Managing Quality and Compliance in a Global and Outsourced Ecosystem
Please join Axendia and Veeva Systems for a complimentary FDANews webinar on March 30th at 1:30 pm EDT.
Are suppliers and contract organizations putting your product’s quality at risk? Learn about industry trends and strategies your company can leverage to gain better control and visibility in our webinar.
What Can Pharma CIOs do to Enable Innovation
What is the role of a CIO in a Pharma / Life-Science company? Traditionally, the role of the CIO has been to manage the IT portfolio, implement systems, manage infrastructure and control IT costs to support the business.
With the unprecedented rate of shift the industry is experiencing, CIO’s can no longer simply be tasked with managing portfolios and budgets.
This was evident at the 2015 CIO Innovation Summit in Kyoto, Japan on October 20th.
There, Executives from leading organizations across the Life-Sciences ecosystem in Asia converged at the Ritz Carlton in Kyoto to learn about industry trends and share success stories and current best practices (cBPs).
Max Carnecchia, BIOVIA’s CEO, set the tone for the event in his opening remarks. His message: “By transforming the pharmaceutical industry through innovation, collaboration and connectivity, we can streamline end-to-end manufacturing, enhance quality and improve compliance in today’s challenging regulatory and risk environment.”
To learn more about illuminating dark data, please click here for a PDF copy of the entire Event Brief.